Table 2.
The serum levels of AngII and KLK1 in the case and control groups.
| Variables | Controls | Cases | t/x2 | p |
|---|---|---|---|---|
| AngII (ng/l) | 119.83 ± 52.80 | 185.04 ± 61.55 | −11.69 | <0.001 |
| KLK1 (ng/ml) | 21.68 ± 13.64 | 22.63 ± 8.69 | −0.853 | 0.394 |
| AngII ≦120 | 122 (56.5%) | 42 (20.2%) | 58.833 | <0.001 |
| >120 | 94 (43.5%) | 166 (79.8%) | ||
| KLK1 ≦22 | 146 (67.6%) | 92 (44.2%) | 23.486 | <0.001 |
| >22 | 70 (32.4%) | 116 (55.8%) | ||
| AngII & KLK1 | 71.724 | <0.001 | ||
| ≦120&≦22 | 92 (42.6%) | 20 (9.6%) | ||
| ≦120&>22 | 30 (13.9%) | 22 (10.6%) | ||
| >120&≦22 | 54 (25.0%) | 72 (34.6%) | ||
| >120&>22 | 40 (18.5%) | 94 (45.2%) |
AngII: angiotensin II; KLK1: tissue kallikrein; AngII&KLK1: Angiotensin II and tissue kallikrein.